Literature DB >> 9610357

Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells.

S M Firth1, S Fanayan, D Benn, R C Baxter.   

Abstract

Insulin-like growth factor binding protein-3 (IGFBP-3) has antiproliferative effects in many cell types but paradoxical growth stimulation has also been reported. In early passages following transfection of T47D breast cancer cells with IGFBP-3 cDNA, the proliferation rate and serum-stimulated DNA synthesis were significantly reduced compared to control cells. Cell cycle analysis indicated that growth-inhibited IGFBP-3-producing cells accumulated in G1 phase. After several passages, the transfected cells became resistant to the inhibitory effects of IGFBP-3 and showed transiently enhanced proliferation rates despite an increased IGFBP-3 concentration in the medium. IGFBP-3 proteolysis did not account for its decreased antiproliferative activity in resistant cells. We hypothesize that development of resistance to the antiproliferative action of IGFBP-3 might be an important step in the malignant progression of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610357     DOI: 10.1006/bbrc.1998.8615

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Insulin-like growth factor binding proteins (IGFBPs) in breast cancer.

Authors:  C M Perks; J M Holly
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

2.  Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

Authors:  Woo-Young Kim; Mi-Jung Kim; Hojin Moon; Ping Yuan; Jin-Soo Kim; Jong-Kyu Woo; Guangcheng Zhang; Young-Ah Suh; Lei Feng; Carmen Behrens; Carolyn S Van Pelt; Hyunseok Kang; J Jack Lee; Waun-Ki Hong; Ignacio I Wistuba; Ho-Young Lee
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

Review 3.  Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.

Authors:  R C Baxter
Journal:  Mol Pathol       Date:  2001-06

4.  IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin.

Authors:  Jamie McIntosh; Godwin Dennison; Jeff M P Holly; Caroline Jarrett; Alexandra Frankow; Emily J Foulstone; Zoe E Winters; Claire M Perks
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

5.  Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells.

Authors:  Mitsuteru Natsuizaka; Shinya Ohashi; Gabrielle S Wong; Azal Ahmadi; Ross A Kalman; Daniela Budo; Andres J Klein-Szanto; Meenhard Herlyn; J Alan Diehl; Hiroshi Nakagawa
Journal:  Carcinogenesis       Date:  2010-05-31       Impact factor: 4.944

6.  Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity.

Authors:  Janet L Martin; Mike Z Lin; Eileen M McGowan; Robert C Baxter
Journal:  J Biol Chem       Date:  2009-07-25       Impact factor: 5.157

Review 7.  IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

Authors:  Claire M Perks; Jeff M P Holly
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-25       Impact factor: 2.673

8.  Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.

Authors:  Sarah B Vestey; Claire M Perks; Chandan Sen; Caroline J Calder; Jeff M P Holly; Zoe E Winters
Journal:  Breast Cancer Res       Date:  2004-11-23       Impact factor: 6.466

Review 9.  Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer.

Authors:  Kamila A Marzec; Robert C Baxter; Janet L Martin
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

10.  Inhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis.

Authors:  Sandra M Saldana; Heng-Huan Lee; Frank J Lowery; Yekaterina B Khotskaya; Weiya Xia; Chenyu Zhang; Shih-Shin Chang; Chao-Kai Chou; Patricia S Steeg; Dihua Yu; Mien-Chie Hung
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.